Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amelgen dose escalation for low progesterone during artificial vitrified/warmed single blastocyst transfer
2020-004112-10Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of progesterone in infertility (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Ongoing pregnancy rate. Started Nov 2020; status: completed.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on 2020-004112-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004112-10.